Anjarium Biosciences AG logo

Anjarium Biosciences AG

DNA to Catalyze Your Advanced Therapies

15 employees · est. 2016 · Schlieren, Switzerland

VS
Aro Biotherapeutics logo

Aro Biotherapeutics

51 employees · est. 2018 · Philadelphia, United States

Anjarium Biosciences AG is the older company (2016 vs 2018); Aro Biotherapeutics is the larger of the two.

Side-by-Side Comparison

Anjarium Biosciences AG Aro Biotherapeutics
Founded
2016 older 2018
Headquarters
Schlieren, Switzerland Philadelphia, United States
Employees
15 51 larger
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care, Health and Wellness
Funding Stage
Series A Series B
Total Funding
$55.50M $166.50M
Funding Rounds
2 4
Services
Synthetic DNA production for cell & gene therapy tools, Enzyme-based DNA synthesis, Lentiviral vector production, mRNA production, R&D and manufacturing workflows optimization, DNA constructs synthesis. Development of Centyrin-based Therapeutic Candidates, Research and Optimization of Receptor-specific Centyrins, Conjugation of Centyrins to Oligonucleotides
Target Customers
Researchers and manufacturers in the biotechnology and pharmaceutical industries. Patients with Genetic Disorders, Biotechnology Industry Partners, Researchers in Genetic Medicine
Taxonomy
Cell And Gene Therapy, DNA Constructs, Genetic Medicines, Non-Viral Gene Therapies, Bioinspired Nanomedicine, Nucleic Acid Synthesis, Enzymatic Platforms, Advanced Therapies, Drug Delivery Systems, Genetic Disease Treatment, Research Tools, Technology Development, Biomedical Innovations, Biotech Solutions, Therapeutic Delivery Systems Genetic Medicines, Tissue-targeted Therapies, Philadelphia, Centyrins, Therapeutic Candidates, Proprietary Protein Technology, Disease Therapies, Drug Development, Biopharmaceuticals, Industry Partnerships, Disease Targeting, Genetic Medicine Innovation
Website
anjarium.com arobiotx.com
Anjarium Biosciences AG logo

About Anjarium Biosciences AG

Anjarium Biosciences AG is a Swiss-based company specializing in cell and gene therapy tools and technology. Founded in 2016, the company's mission is to expedite the discovery and delivery cycle of genetic medicines. Anjarium's innovative technology facilitates the creation of customizable DNA cons...

Aro Biotherapeutics logo

About Aro Biotherapeutics

Aro Biotherapeutics, founded in 2018 and headquartered in the United States, is at the forefront of biotechnology innovation. The company specializes in developing tissue-targeted genetic medicines, leveraging its proprietary Centyrins technology. This platform is propelling the creation of a robust...

We will tell you when either one moves

BounceWatch watches Anjarium Biosciences AG and Aro Biotherapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Anjarium Biosciences A... and Aro Biotherapeutics — by email.

Frequently Asked Questions

Anjarium Biosciences AG — DNA to Catalyze Your Advanced Therapies. Aro Biotherapeutics — . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Anjarium Biosciences AG has raised $55.50M while Aro Biotherapeutics has raised $166.50M.
Anjarium Biosciences AG and Aro Biotherapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Anjarium Biosciences AG with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Anjarium Biosciences AG on 25 Mar 2025, and Aro Biotherapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes